Search hospitals > Pennsylvania > Lebanon
Sechler Family Cancer Center
Claim this profileLebanon, Pennsylvania 17042
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
Conducts research for Recurrence
72 reported clinical trials
9 medical researchers
Summary
Sechler Family Cancer Center is a medical facility located in Lebanon, Pennsylvania. This center is recognized for care of Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Recurrence and other specialties. Sechler Family Cancer Center is involved with conducting 72 clinical trials across 113 conditions. There are 9 research doctors associated with this hospital, such as Chanh T. Huynh, Amit B. Shah, Dan Sotirescu, and Joseph Kannarkatt.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Chanh T. HuynhAdams Cancer Center1 year of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
20 reported clinical trials
37 drugs studied
Amit B. ShahWellSpan Health-York Cancer Center3 years of reported clinical research
Studies Prostate Cancer
Studies Small Cell Lung Cancer
21 reported clinical trials
63 drugs studied
Dan SotirescuEphrata Cancer Center4 years of reported clinical research
Studies Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
28 drugs studied
Joseph KannarkattWellSpan Medical Oncology and Hematology3 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
31 drugs studied
Clinical Trials running at Sechler Family Cancer Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Small Cell Lung Cancer
Cancer
Lung Carcinoma
Pancreatic Cancer
Recurrence
Small Cell Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sechler Family Cancer Center?
Sechler Family Cancer Center is a medical facility located in Lebanon, Pennsylvania. This center is recognized for care of Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Recurrence and other specialties. Sechler Family Cancer Center is involved with conducting 72 clinical trials across 113 conditions. There are 9 research doctors associated with this hospital, such as Chanh T. Huynh, Amit B. Shah, Dan Sotirescu, and Joseph Kannarkatt.